Background: Dyslipidemia is highly prevalent and is one of the major risk factors for cardiovascular disease in Lithuania. The purpose of this study was to determine the prevalence of severe dyslipidemia in Lithuanian middle aged primary prevention population and to investigate cardiovascular risk profile.& para;& para;Methods: The group of 83,376 people were examined in the Lithuanian High Cardiovascular Risk primary prevention program (LitHiR), during 2009-2015 years. This study recruited middle aged men and women without overt cardiovascular disease. The prevalence of cardiovascular risk factors was compared between severe dyslipidemia group and control group.& para;& para;Results: Severe dyslipidemia was present in 13.5% (11265) of the ...
BACKGROUND AND OBJECTIVES: Dyslipidemia is a modifiable major risk factor for coronary heart diseas...
Background and Objective. To date, the epidemiological studies of noncommunicable diseases in Latvia...
Background: The studies have shown that metabolic syndrome (MetS) leads to an increase twice as much...
Abstract Background Dyslipidemia is highly prevalent and is one of the major risk factors for cardio...
Background: Cardiovascular mortality in Lithuania is extremely high and abnormal lipid levels are ve...
Abstract Background Cardiovascular mortality in Lithuania is extremely high and abnormal lipid level...
The aim of this study was to provide reliable information on dyslipidaemias, to estimate the trend o...
Background: Atherogenic dyslipidemia (AD) is a blood serum lipid profile abnormality characterized b...
Dyslipidemia is recognized as one of the major risk factors of cardiovascular diseases (CVD). Abnorm...
Cardiovascular disease (CVD) is still a major cause of premature death across Europe and in our coun...
Background and aims: This study aimed to estimate the prevalence of cardiovascular risk factors in m...
Background and objective: The Baltic nations (Estonia, Latvia, and Lithuania) are profoundly affecte...
Objective: Cardiovascular diseases (CVD) are a major cause of mortality and morbidity in Poland. Dat...
AIMS:This study investigated the trends and levels of the prevalence of health factors, and the asso...
Background and objective: Cardiovascular diseases are still a major public health concern in Estonia...
BACKGROUND AND OBJECTIVES: Dyslipidemia is a modifiable major risk factor for coronary heart diseas...
Background and Objective. To date, the epidemiological studies of noncommunicable diseases in Latvia...
Background: The studies have shown that metabolic syndrome (MetS) leads to an increase twice as much...
Abstract Background Dyslipidemia is highly prevalent and is one of the major risk factors for cardio...
Background: Cardiovascular mortality in Lithuania is extremely high and abnormal lipid levels are ve...
Abstract Background Cardiovascular mortality in Lithuania is extremely high and abnormal lipid level...
The aim of this study was to provide reliable information on dyslipidaemias, to estimate the trend o...
Background: Atherogenic dyslipidemia (AD) is a blood serum lipid profile abnormality characterized b...
Dyslipidemia is recognized as one of the major risk factors of cardiovascular diseases (CVD). Abnorm...
Cardiovascular disease (CVD) is still a major cause of premature death across Europe and in our coun...
Background and aims: This study aimed to estimate the prevalence of cardiovascular risk factors in m...
Background and objective: The Baltic nations (Estonia, Latvia, and Lithuania) are profoundly affecte...
Objective: Cardiovascular diseases (CVD) are a major cause of mortality and morbidity in Poland. Dat...
AIMS:This study investigated the trends and levels of the prevalence of health factors, and the asso...
Background and objective: Cardiovascular diseases are still a major public health concern in Estonia...
BACKGROUND AND OBJECTIVES: Dyslipidemia is a modifiable major risk factor for coronary heart diseas...
Background and Objective. To date, the epidemiological studies of noncommunicable diseases in Latvia...
Background: The studies have shown that metabolic syndrome (MetS) leads to an increase twice as much...